These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 23785136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Infantile gangliosidoses: Mapping a timeline of clinical changes.
    Jarnes Utz JR, Kim S, King K, Ziegler R, Schema L, Redtree ES, Whitley CB.
    Mol Genet Metab; 2017 Jun 15; 121(2):170-179. PubMed ID: 28476546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G, Linke T, Uhlhorn-Dierks G, Sandhoff K.
    J Biol Chem; 2000 Nov 17; 275(46):35814-9. PubMed ID: 10942779
    [Abstract] [Full Text] [Related]

  • 9. The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.
    Regier DS, Proia RL, D'Azzo A, Tifft CJ.
    Pediatr Endocrinol Rev; 2016 Jun 17; 13 Suppl 1(Suppl 1):663-73. PubMed ID: 27491214
    [Abstract] [Full Text] [Related]

  • 10. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E, Sandhoff K.
    Proc Natl Acad Sci U S A; 1978 Aug 17; 75(8):3979-83. PubMed ID: 99746
    [Abstract] [Full Text] [Related]

  • 11. Biochemistry and genetics of gangliosidoses.
    Sandhoff K, Christomanou H.
    Hum Genet; 1979 Aug 17; 50(2):107-43. PubMed ID: 116955
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
    Agmon V, Khosravi R, Marchesini S, Dinur T, Dagan A, Gatt S, Navon R.
    Clin Chim Acta; 1996 Mar 29; 247(1-2):105-20. PubMed ID: 8920231
    [Abstract] [Full Text] [Related]

  • 15. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
    Kobayashi T, Goto I, Okada S, Orii T, Ohno K, Nakano T.
    J Neurochem; 1992 Oct 29; 59(4):1452-8. PubMed ID: 1402895
    [Abstract] [Full Text] [Related]

  • 16. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS, Mirenburg TV, Krasnopolskaya XD.
    J Inherit Metab Dis; 1994 Oct 29; 17(1):104-11. PubMed ID: 8051915
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ganglioside Metabolism and Its Inherited Diseases.
    Breiden B, Sandhoff K.
    Methods Mol Biol; 2018 Oct 29; 1804():97-141. PubMed ID: 29926406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
    Kohyama M, Yabuki A, Ochiai K, Nakamoto Y, Uchida K, Hasegawa D, Takahashi K, Kawaguchi H, Tsuboi M, Yamato O.
    BMC Vet Res; 2016 Mar 31; 12():67. PubMed ID: 27036194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.